Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmad Isbitan, MD
Saint Michael's Medical Center
Study Chair - Ashraf Jmeian, MD
Saint Michael's Medical Center
Study Chair - Fayez Shamoon, MD,FACC
Saint Michael's Medical Center
Study Director - Habib Habib, MD
Saint Michael's Medical Center
Principal Investigator - Vincent Debari, PhD
Saint Michael's Medical Center
Study Chair - yaser elnhar, MD
Saint Michael's Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Michael'S Medical Center
Newark, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 30 Apr 2014
- Completion
- 31 May 2014
- Last update posted
- 22 Feb 2013
- Registered enrollment
- 100
- Registry id
- NCT01609569
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.